Deficiency of Interleukin-1 Receptor Antagonist

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

  This clinical trial update describes an ongoing study on the natural history, pathogenesis, and outcomes of autoinflammatory diseases includ…

• CLINICAL_TRIALS trial_result · 2017-10-16
  Clinical Trial Update: Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA) [Phase 2]

  A Phase 2 trial of rilonacept for Deficiency of interleukin-1 receptor antagonist (DIRA) has completed and posted results.